Despite the downward trend in earnings at Supernus Pharmaceuticals (NASDAQ:SUPN) the stock advances 3.1%, bringing five-year gains to 56%

Can the 3 Best-Performing Stock Market Sectors in 2024 Crush the S&P 500 Again in 2025?

Those who invested in AeroVironment (NASDAQ:AVAV) three years ago are up 168%

The King Of The 21st Century Wears A Golden Crown

European Stock Futures Fall Before US Jobs Data: Markets Wrap

Dow Jones Futures Fall, Tesla Launches New Model Y; Nvidia Chipmaker, Jobs Report Due